Data Material
ALK Medical Affairs Canada provides the resources found on this website for Canadian healthcare professionals only.
Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis
Journal Publication
Click to view
By clicking here, you agree to visiting a site maintained by a third party, who is solely responsible for its contents.
Short Summary: In this cost minimization analysis, the ragweed SLIT-tablet provided estimated cost savings from a public payer perspective for the treatment of ragweed ARC in Canadian children compared with SCIT or MRPATA.